Mount Sinai Division of Gastroenterology
@mountsinaigi.bsky.social
The Mount Sinai Hospital is ranked No. 8 in the nation for Gastroenterology/GI Surgery by U.S. News & World Report® for 2024-25.
Congratulations to Jean-Frédéric Colombel, MD, selected to deliver the 31st Anatomy Lesson in Amsterdam, where he will present on advancing early detection and prevention in IBD. Learn more: bit.ly/3JD7o4n
November 10, 2025 at 9:39 PM
Congratulations to Jean-Frédéric Colombel, MD, selected to deliver the 31st Anatomy Lesson in Amsterdam, where he will present on advancing early detection and prevention in IBD. Learn more: bit.ly/3JD7o4n
Can prevention start on the plate? A meta-analysis of 72 prospective studies links dietary patterns to #CrohnsDisease risk. Findings support the potential for developing diet-based #IBD prevention recommendations and future clinical trials. Read the article here to learn how:
tinyurl.com/4sjf6hcv
tinyurl.com/4sjf6hcv
Impact of diet on inflammatory bowel disease risk: systematic review, meta-analyses and implications for prevention
Data on dietary risk factors for inflammatory bowel disease (IBD), while extensive, are inconsistent. Our aim was to systematically review and meta-an…
www.sciencedirect.com
July 24, 2025 at 5:19 PM
Can prevention start on the plate? A meta-analysis of 72 prospective studies links dietary patterns to #CrohnsDisease risk. Findings support the potential for developing diet-based #IBD prevention recommendations and future clinical trials. Read the article here to learn how:
tinyurl.com/4sjf6hcv
tinyurl.com/4sjf6hcv
Brijen Shah, MD shares with USA Today that "Acid reflux can be managed by most people if they learn the behavior changes they can make and how to appropriately use over-the-counter medications."
For further insights from Dr. Shah and more info on the topic, read the full article here: rb.gy/k8b0h2
For further insights from Dr. Shah and more info on the topic, read the full article here: rb.gy/k8b0h2
Acid reflux impacts about 20% of American adults. What causes it?
Gastroesophageal reflux disease (GERD) impacts about 20% of adults in the U.S. Here's what experts want you to know about causes and treatments.
rb.gy
July 22, 2025 at 7:17 PM
Brijen Shah, MD shares with USA Today that "Acid reflux can be managed by most people if they learn the behavior changes they can make and how to appropriately use over-the-counter medications."
For further insights from Dr. Shah and more info on the topic, read the full article here: rb.gy/k8b0h2
For further insights from Dr. Shah and more info on the topic, read the full article here: rb.gy/k8b0h2
New data from a first-of-its-kind, head-to-head, double blind trial led by Bruce Sands, MD and team shows guselkumab outperforms the leading #Crohns treatment, even in patients who have failed other biologics. This breakthrough sets a new standard in #IBD care.
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
July 18, 2025 at 2:33 PM
New data from a first-of-its-kind, head-to-head, double blind trial led by Bruce Sands, MD and team shows guselkumab outperforms the leading #Crohns treatment, even in patients who have failed other biologics. This breakthrough sets a new standard in #IBD care.
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Mount Sinai researchers are launching a study on GLP-1 agonists as a novel gut-healing therapy for Crohn’s disease, shifting focus from inflammation suppression to epithelial repair. Funded by a $3M Helmsley grant. Learn more: reports.mountsinai.org/article/gi20...
July 14, 2025 at 6:50 PM
Mount Sinai researchers are launching a study on GLP-1 agonists as a novel gut-healing therapy for Crohn’s disease, shifting focus from inflammation suppression to epithelial repair. Funded by a $3M Helmsley grant. Learn more: reports.mountsinai.org/article/gi20...
Congrats to Palak Rajauria on winning “Best Research Presentation” at this year’s IBD Retreat! Her talk highlights Dr. Ryan Ungaro’s team’s tool that may predict #CrohnsDisease 2 years before diagnosis with 99% specificity.
Read more: wb.md/3ZZ8rk6
Read more: wb.md/3ZZ8rk6
June 30, 2025 at 2:42 PM
Congrats to Palak Rajauria on winning “Best Research Presentation” at this year’s IBD Retreat! Her talk highlights Dr. Ryan Ungaro’s team’s tool that may predict #CrohnsDisease 2 years before diagnosis with 99% specificity.
Read more: wb.md/3ZZ8rk6
Read more: wb.md/3ZZ8rk6
Stephanie Gold, MD, and Elizabeth Spencer, MD, discuss their research on trends in the use of GLP-1 receptor agonists in patients with IBD as well as their safety and efficacy in this patient population. Learn more: bit.ly/4dsRN1H
May 22, 2025 at 6:43 PM
Stephanie Gold, MD, and Elizabeth Spencer, MD, discuss their research on trends in the use of GLP-1 receptor agonists in patients with IBD as well as their safety and efficacy in this patient population. Learn more: bit.ly/4dsRN1H
Mount Sinai is proud to present groundbreaking research and clinical insights at #DDW2025.
View the full list of presenters and download our schedule:
icahn.foleon.com/conferences/...
#HereForDDW #WeFindAWay
View the full list of presenters and download our schedule:
icahn.foleon.com/conferences/...
#HereForDDW #WeFindAWay
May 1, 2025 at 6:15 PM
Mount Sinai is proud to present groundbreaking research and clinical insights at #DDW2025.
View the full list of presenters and download our schedule:
icahn.foleon.com/conferences/...
#HereForDDW #WeFindAWay
View the full list of presenters and download our schedule:
icahn.foleon.com/conferences/...
#HereForDDW #WeFindAWay
Congratulations to Dr. Pascale M. White, honored with the inaugural AGA–Pfizer Beacon of Hope Award for her leadership in advancing gender and health equity in GI.
She will be recognized at the #AGA Beacons of Hope Women’s Luncheon at #DDW2025.
🔗 bit.ly/4cztqPk
@amergastroassn.bsky.social
She will be recognized at the #AGA Beacons of Hope Women’s Luncheon at #DDW2025.
🔗 bit.ly/4cztqPk
@amergastroassn.bsky.social
April 17, 2025 at 5:25 PM
Congratulations to Dr. Pascale M. White, honored with the inaugural AGA–Pfizer Beacon of Hope Award for her leadership in advancing gender and health equity in GI.
She will be recognized at the #AGA Beacons of Hope Women’s Luncheon at #DDW2025.
🔗 bit.ly/4cztqPk
@amergastroassn.bsky.social
She will be recognized at the #AGA Beacons of Hope Women’s Luncheon at #DDW2025.
🔗 bit.ly/4cztqPk
@amergastroassn.bsky.social
IBDebrief enhances #IBD knowledge for community #gastroenterology providers. Submit cases for expert discussion & join a "Hot Topics in IBD" review. Sessions are on the first Tuesday monthly, 5–6 PM, with in-person & virtual options.
icahn.mssm.edu/about/depart...
icahn.mssm.edu/about/depart...
IBDebrief | Icahn School of Medicine
icahn.mssm.edu
April 2, 2025 at 2:55 PM
IBDebrief enhances #IBD knowledge for community #gastroenterology providers. Submit cases for expert discussion & join a "Hot Topics in IBD" review. Sessions are on the first Tuesday monthly, 5–6 PM, with in-person & virtual options.
icahn.mssm.edu/about/depart...
icahn.mssm.edu/about/depart...
Reposted by Mount Sinai Division of Gastroenterology
📚NEW #gdTcell PAPER ALERT! Dysregulation of γδ intraepithelial lymphocytes precedes Crohn’s disease–like ileitis | Science Immunology
Bluetorial coming soon!!! #gastrosky #GIsky #IBDsky @nbgolovchenko.bsky.social @squeakyanimal.bsky.social @andrewfong.bsky.social
Bluetorial coming soon!!! #gastrosky #GIsky #IBDsky @nbgolovchenko.bsky.social @squeakyanimal.bsky.social @andrewfong.bsky.social
Dysregulation of γδ intraepithelial lymphocytes precedes Crohn’s disease–like ileitis
Multiple layers of γδ IEL dysregulation and loss of their immunosuppressive capacity occur before the onset of chronic ileitis.
www.science.org
March 21, 2025 at 6:14 PM
📚NEW #gdTcell PAPER ALERT! Dysregulation of γδ intraepithelial lymphocytes precedes Crohn’s disease–like ileitis | Science Immunology
Bluetorial coming soon!!! #gastrosky #GIsky #IBDsky @nbgolovchenko.bsky.social @squeakyanimal.bsky.social @andrewfong.bsky.social
Bluetorial coming soon!!! #gastrosky #GIsky #IBDsky @nbgolovchenko.bsky.social @squeakyanimal.bsky.social @andrewfong.bsky.social
March is #ColorectalCancerAwarenessMonth. Join Mount Sinai for educational events across the System from 9 AM - 3 PM. Speak with experts, learn about screenings, and take charge of your health. Call Mount Sinai's CHOICE Program at 212-824-7887 to discuss screening options.
#CRC #ColonCancer
#CRC #ColonCancer
March 12, 2025 at 8:21 PM
March is #ColorectalCancerAwarenessMonth. Join Mount Sinai for educational events across the System from 9 AM - 3 PM. Speak with experts, learn about screenings, and take charge of your health. Call Mount Sinai's CHOICE Program at 212-824-7887 to discuss screening options.
#CRC #ColonCancer
#CRC #ColonCancer
A Mount Sinai-led study found that 60% of cholangiocarcinoma samples had high B7-H4 levels, a protein that inhibits T cell immunity and may drive tumor growth. This discovery could lead to new targeted therapies. Learn more: reports.mountsinai.org/article/live...
March 12, 2025 at 8:17 PM
A Mount Sinai-led study found that 60% of cholangiocarcinoma samples had high B7-H4 levels, a protein that inhibits T cell immunity and may drive tumor growth. This discovery could lead to new targeted therapies. Learn more: reports.mountsinai.org/article/live...
A first-in-class monoclonal antibody therapy showed promise in a phase 2 trial, inducing remission in ulcerative colitis patients who hadn’t responded to other treatments. The Mount Sinai-led study offers new hope for those not helped by existing therapies. reports.mountsinai.org/article/gast...
February 18, 2025 at 4:04 PM
A first-in-class monoclonal antibody therapy showed promise in a phase 2 trial, inducing remission in ulcerative colitis patients who hadn’t responded to other treatments. The Mount Sinai-led study offers new hope for those not helped by existing therapies. reports.mountsinai.org/article/gast...
Mount Sinai launched a program for Crohn's disease that combines biologic therapy with brain-gut behavior therapy, helping patients build resilience and take control of their disease.
Learn more: reports.mountsinai.org/article/gast...
#CrohnsDisease #IBD #GutHealth #Resilience
Learn more: reports.mountsinai.org/article/gast...
#CrohnsDisease #IBD #GutHealth #Resilience
February 12, 2025 at 5:26 PM
Mount Sinai launched a program for Crohn's disease that combines biologic therapy with brain-gut behavior therapy, helping patients build resilience and take control of their disease.
Learn more: reports.mountsinai.org/article/gast...
#CrohnsDisease #IBD #GutHealth #Resilience
Learn more: reports.mountsinai.org/article/gast...
#CrohnsDisease #IBD #GutHealth #Resilience
Reposted by Mount Sinai Division of Gastroenterology
Wrapping up #CCCongress25 with my favorite session on how we can prevent #IBD before it starts. Excellent talks from @mountsinaigi.bsky.social colleagues Inga Peter & @mehandrulab.bsky.social and Ken Croitoru on the #GEM cohort. 1/n
a sign that says san francisco is lit up in front of a city skyline
ALT: a sign that says san francisco is lit up in front of a city skyline
media.tenor.com
February 8, 2025 at 7:43 PM
Wrapping up #CCCongress25 with my favorite session on how we can prevent #IBD before it starts. Excellent talks from @mountsinaigi.bsky.social colleagues Inga Peter & @mehandrulab.bsky.social and Ken Croitoru on the #GEM cohort. 1/n
Health Equity in Action for Liver and Digestive Diseases (HEALD) focuses on health equity initiatives within the Divisions of Gastroenterology and Liver Diseases. It will address disparities in colorectal and liver cancer screening and introduce a dashboard to track health equity. bit.ly/3En3QQy
February 5, 2025 at 6:59 PM
Health Equity in Action for Liver and Digestive Diseases (HEALD) focuses on health equity initiatives within the Divisions of Gastroenterology and Liver Diseases. It will address disparities in colorectal and liver cancer screening and introduce a dashboard to track health equity. bit.ly/3En3QQy
Mount Sinai’s iNourish program supports Crohn’s & colitis patients with nutrition-focused care & research. A dedicated clinic tackles malnutrition, affecting up to 70% of hospitalized IBD patients. Learn more: bit.ly/4jDlO1u
#IBD #Nutrition #Crohnscolitis #WeFindAWay
#IBD #Nutrition #Crohnscolitis #WeFindAWay
January 31, 2025 at 7:34 PM
Mount Sinai’s iNourish program supports Crohn’s & colitis patients with nutrition-focused care & research. A dedicated clinic tackles malnutrition, affecting up to 70% of hospitalized IBD patients. Learn more: bit.ly/4jDlO1u
#IBD #Nutrition #Crohnscolitis #WeFindAWay
#IBD #Nutrition #Crohnscolitis #WeFindAWay
Mount Sinai researchers show wearable devices like Apple Watches can predict #IBD flare-ups, enabling continuous, non-invasive monitoring. Learn more: bit.ly/3PSlrlP
#IBD #WearableTech
#IBD #WearableTech
January 28, 2025 at 7:55 PM
Mount Sinai researchers show wearable devices like Apple Watches can predict #IBD flare-ups, enabling continuous, non-invasive monitoring. Learn more: bit.ly/3PSlrlP
#IBD #WearableTech
#IBD #WearableTech
Join us on Feb 28, 2025, 8 AM–4 PM for the 20th Annual Mount Sinai IBD Consultant’s Course! Explore cutting-edge strategies to improve diagnosis, treatment & care for IBD patients. Learn more & register: bit.ly/4gPq9Ne
#IBD #HealthcareEducation #MountSinai #InflammatoryBowelDisease
#IBD #HealthcareEducation #MountSinai #InflammatoryBowelDisease
January 28, 2025 at 3:56 PM
Join us on Feb 28, 2025, 8 AM–4 PM for the 20th Annual Mount Sinai IBD Consultant’s Course! Explore cutting-edge strategies to improve diagnosis, treatment & care for IBD patients. Learn more & register: bit.ly/4gPq9Ne
#IBD #HealthcareEducation #MountSinai #InflammatoryBowelDisease
#IBD #HealthcareEducation #MountSinai #InflammatoryBowelDisease
The 2025 #Gastroenterology and #GI Surgery Specialty Report is here. Discover how Mount Sinai is advancing care with innovative treatments, groundbreaking research, and a patient-centered approach. Explore our key achievements and vision for the future of GI health. Read the report: bit.ly/40APpzO
January 27, 2025 at 8:29 PM
The 2025 #Gastroenterology and #GI Surgery Specialty Report is here. Discover how Mount Sinai is advancing care with innovative treatments, groundbreaking research, and a patient-centered approach. Explore our key achievements and vision for the future of GI health. Read the report: bit.ly/40APpzO